Trial Details

Not recruiting
Basic Information
Clinical ID c3253
Identifier NCT01221818
Trial Title A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Inflammatory Bowel Disease
Interventions Drug: E6007;Drug: E6007;Drug: E6007;Drug: E6007;Drug: E6007;Drug: E6007
Participant Information
Sponsor Eisai Inc.
City -
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type Interventional
Phase PHASE1
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -